Eikon is uncovering the potential of Single Molecule Tracking (SMT) across the drug discovery process. (ref) Our technology uniquely positions us to discover breakthrough medicines.
The ability to image and quantify the dynamic movement of proteins reveals novel druggable biology for difficult targets. These mechanisms can be used across the drug discovery paradigm in high-throughput screens, as secondary assays, or to optimize compounds against a given target. The broad utilization of protein dynamics, coupled with a full complement of drug discovery assay systems, will enable discovery of new therapeutics for previously undruggable targets.
Our pipeline is designed to achieve impactful therapeutics for unmet medical needs.
Meet the team pioneering SMT in drug discovery